Mabworks Biotech has a total of 147 patents globally, out of which 63 have been granted. Of these 147 patents, more than 71% patents are active. China is where Mabworks Biotech has filed the maximum number of patents, followed by United states of America and Hong Kong (S.A.R.). Parallelly, China seems to be the main focused R&D centre and also is the origin country of Mabworks Biotech.
Mabworks Biotech was founded in 2002. The company develops specialized antibody drugs focused on cancer biology. With expertise in creating pre-clinical and clinical drugs for tumors and autoimmune diseases, the company leverages advance in immunology and cancer biology to support research and pharmaceutical solutions for disease treatment.
Do read about some of the most popular patents of Mabworks Biotech which have been covered by us in this article and also you can find Mabworks Biotech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mabworks Biotech patent portfolio.
How many patents does Mabworks Biotech have?
Mabworks Biotech has a total of 147 patents globally. These patents belong to 47 unique patent families. Out of 147 patents, 105 patents are active.
How Many Patents did Mabworks Biotech File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Mabworks Biotech Applications Filed | Mabworks Biotech Patents Granted |
2024 | 3 | 5 |
2023 | 20 | 9 |
2022 | 15 | 4 |
2021 | 20 | 12 |
2020 | 15 | 14 |
2019 | 36 | 7 |
2017 | 15 | 2 |
2016 | 3 | – |
2015 | 1 | – |
2014 | 1 | 1 |
How many Mabworks Biotech patents are Alive/Dead?
Worldwide Patents
How Many Patents did Mabworks Biotech File in Different Countries?
Countries in which Mabworks Biotech Filed Patents
Country | Patents |
China | 56 |
United States of America | 23 |
Hong Kong (S.A.R.) | 21 |
Europe (EPO) | 9 |
Australia | 9 |
Canada | 5 |
Germany | 2 |
Taiwan | 2 |
Austria | 1 |
Japan | 1 |
Where are Research Centers of Mabworks Biotech Patents Located?
10 Best Mabworks Biotech Patents
US10421817B1 is the most popular patent in the Mabworks Biotech portfolio. It has received 19 citations so far from companies like Novarock Biotherapeutics, Rongchang Biopharmaceuticals (Yantai), Courreges Medical Company.
Below is the list of 10 most cited patents of Mabworks Biotech:
Publication Number | Citation Count |
US10421817B1 | 19 |
US10570210B1 | 12 |
WO2018014864A1 | 12 |
CN101653749A | 11 |
CN1896229A | 10 |
US9745382B1 | 8 |
CN107446045A | 8 |
CN1523350A | 8 |
WO2020147321A1 | 7 |
CN104278038A | 6 |
What are Mabworks Biotech key innovation segments?
What Technologies are Covered by Mabworks Biotech?
The chart below distributes patents filed by Mabworks Biotech in different countries on the basis of the technology protected in patents. It also represents the markets where Mabworks Biotech thinks it’s important to protect particular technology inventions.
R&D Focus: How has Mabworks Biotech search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Mabworks Biotech?